251 related articles for article (PubMed ID: 32802959)
1. Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment.
Łaniewski P; Cui H; Roe DJ; Chase DM; Herbst-Kralovetz MM
NPJ Precis Oncol; 2020; 4():22. PubMed ID: 32802959
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition.
Kaelin EA; Skidmore PT; Łaniewski P; Holland LA; Chase DM; Herbst-Kralovetz MM; Lim ES
mSystems; 2022 Apr; 7(2):e0006422. PubMed ID: 35343798
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
[TBL] [Abstract][Full Text] [Related]
4. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis.
Łaniewski P; Cui H; Roe DJ; Barnes D; Goulder A; Monk BJ; Greenspan DL; Chase DM; Herbst-Kralovetz MM
Sci Rep; 2019 May; 9(1):7333. PubMed ID: 31089160
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment.
Bokulich NA; Łaniewski P; Adamov A; Chase DM; Caporaso JG; Herbst-Kralovetz MM
PLoS Comput Biol; 2022 Feb; 18(2):e1009876. PubMed ID: 35196323
[TBL] [Abstract][Full Text] [Related]
6. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
Łaniewski P; Barnes D; Goulder A; Cui H; Roe DJ; Chase DM; Herbst-Kralovetz MM
Sci Rep; 2018 May; 8(1):7593. PubMed ID: 29765068
[TBL] [Abstract][Full Text] [Related]
7. Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy.
López-Filloy M; Cortez FJ; Gheit T; Cruz Y Cruz O; Cruz-Talonia F; Chávez-Torres M; Arteaga-Gómez C; Mancilla-Herrera I; Montesinos JJ; Cortés-Morales VA; Aguilar C; Tommasino M; Pinto-Cardoso S; Rocha-Zavaleta L
Front Cell Infect Microbiol; 2022; 12():884272. PubMed ID: 35656032
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
Tosado-Rodríguez E; Mendez LB; Espino AM; Dorta-Estremera S; Aquino EE; Romaguera J; Godoy-Vitorino F
PLoS One; 2023; 18(12):e0284673. PubMed ID: 38064478
[TBL] [Abstract][Full Text] [Related]
9. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.
Sims TT; Colbert LE; Klopp AH
J Immunother Precis Oncol; 2021 May; 4(2):72-78. PubMed ID: 35663536
[TBL] [Abstract][Full Text] [Related]
11. Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection.
Qingqing B; Jie Z; Songben Q; Juan C; Lei Z; Mu X
Microb Pathog; 2021 Mar; 152():104617. PubMed ID: 33207260
[TBL] [Abstract][Full Text] [Related]
12. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.
Kawahara R; Fujii T; Kukimoto I; Nomura H; Kawasaki R; Nishio E; Ichikawa R; Tsukamoto T; Iwata A
Sci Rep; 2021 Jan; 11(1):2156. PubMed ID: 33495564
[TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women.
Teka B; Yoshida-Court K; Firdawoke E; Chanyalew Z; Gizaw M; Addissie A; Mihret A; Colbert LE; Napravnik TC; El Alam MB; Lynn EJ; Mezzari M; Anuja J; Kantelhardt EJ; Kaufmann AM; Klopp AH; Abebe T
Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110255
[TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization.
Zheng X; Hu N; Liu J; Zhao K; Li H; Wang J; Zhang M; Zhang L; Song L; Lyu Y; Cui M; Ding L; Wang J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17371-17381. PubMed ID: 37843556
[TBL] [Abstract][Full Text] [Related]
15. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
17. Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection.
Zhang N; Chen Z; Huang M; Lu Q; Yang H; Xiang J; Yang J; Peng Y; Wang G; Han N; Min X; Huang J
J Med Virol; 2024 Feb; 96(2):e29451. PubMed ID: 38305046
[TBL] [Abstract][Full Text] [Related]
18. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
[TBL] [Abstract][Full Text] [Related]
19. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.
Sadeghirad H; Liu N; Monkman J; Ma N; Cheikh BB; Jhaveri N; Tan CW; Warkiani ME; Adams MN; Nguyen Q; Ladwa R; Braubach O; O'Byrne K; Davis M; Hughes BGM; Kulasinghe A
Front Immunol; 2023; 14():1135489. PubMed ID: 37153589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
